- Home
- RGNX vs HPP Comparison
RGNX vs HPP Comparison
Compare RGNX & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- HPP
- Stock Information
- Founded
- RGNX 2008
- HPP 1997
- Country
- RGNX United States
- HPP United States
- Employees
- RGNX N/A
- HPP N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- HPP Real Estate
- Sector
- RGNX Health Care
- HPP Finance
- Exchange
- RGNX Nasdaq
- HPP Nasdaq
- Market Cap
- RGNX 661.2M
- HPP 648.9M
- IPO Year
- RGNX 2015
- HPP 2010
- Fundamental
- Price
- RGNX $11.86
- HPP $1.72
- Analyst Decision
- RGNX Strong Buy
- HPP Hold
- Analyst Count
- RGNX 7
- HPP 11
- Target Price
- RGNX $30.29
- HPP $3.04
- AVG Volume (30 Days)
- RGNX 537.9K
- HPP 7.5M
- Earning Date
- RGNX 11-06-2025
- HPP 11-05-2025
- Dividend Yield
- RGNX N/A
- HPP N/A
- EPS Growth
- RGNX N/A
- HPP N/A
- EPS
- RGNX N/A
- HPP N/A
- Revenue
- RGNX $161,318,000.00
- HPP $781,676,000.00
- Revenue This Year
- RGNX $198.02
- HPP N/A
- Revenue Next Year
- RGNX $2.67
- HPP $7.04
- P/E Ratio
- RGNX N/A
- HPP N/A
- Revenue Growth
- RGNX 91.30
- HPP N/A
- 52 Week Low
- RGNX $5.04
- HPP $1.67
- 52 Week High
- RGNX $13.93
- HPP $3.96
- Technical
- Relative Strength Index (RSI)
- RGNX 53.04
- HPP 24.16
- Support Level
- RGNX $10.70
- HPP $2.07
- Resistance Level
- RGNX $12.05
- HPP $2.45
- Average True Range (ATR)
- RGNX 0.73
- HPP 0.15
- MACD
- RGNX -0.10
- HPP -0.05
- Stochastic Oscillator
- RGNX 79.32
- HPP 5.81
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About HPP Hudson Pacific Properties Inc.
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.